Insider Transactions Reported by 10 Insiders of ENDRA Life Sciences Inc.

Symbol
NDRA on Nasdaq
Location
3600 Green Court, Suite 350, Ann Arbor, MI

There are no Buy or Sell transactions made by insiders since 12/11/2024

ENDRA Life Sciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Digiandomenico Anthony Director $1.54M Oct 10, 2025
Michael M. Thornton Chief Technology Officer $56.3K May 18, 2023
Michael Harsh Director $18.1K Jun 11, 2025
Lou Basenese Director $18.1K Jun 11, 2025
Irina Pestrikova Senior Director, Finance Jan 30, 2023
Alexander Y. Tokman Director Jan 2, 2024
Francois R. Michelon Chief Executive Officer, Director Jan 30, 2023
UBS Group AG Market maker/broker-dealer Aug 27, 2024
Richard Jacroux Chief Financial Officer Aug 8, 2024
Renaud B. Maloberti Chief Commercial Officer Mar 28, 2022

Recent Insider Transactions by Companies or Individuals for ENDRA Life Sciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.